Mutational induction in SARS-CoV-2 major lineages by experimental exposure to neutralising sera
- PMID: 35864211
- PMCID: PMC9302871
- DOI: 10.1038/s41598-022-16533-4
Mutational induction in SARS-CoV-2 major lineages by experimental exposure to neutralising sera
Abstract
The ongoing evolution of SARS-CoV-2 and the emergence of new viral variants bearing specific escape mutations responsible for immune evasion from antibody neutralisation has required a more accurate characterisation of the immune response as one of the evolutive forces behind viral adaptation to a largely immunised human population. In this work, culturing in the presence of neutralising sera vigorously promoted mutagenesis leading to the acquisition of known escape mutations on the spike as well as new presumptive escape mutations on structural proteins whose role as target of the neutralizing antibody response might have been thus far widely neglected. From this perspective, this study, in addition to tracing the past evolution of the species back to interactions with neutralising antibody immune response, also offers a glimpse into future evolutive scenarios.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures


Similar articles
-
Sensitivity of two SARS-CoV-2 variants with spike protein mutations to neutralising antibodies.Virus Genes. 2021 Dec;57(6):502-509. doi: 10.1007/s11262-021-01871-8. Epub 2021 Oct 4. Virus Genes. 2021. PMID: 34608598 Free PMC article.
-
Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants.Genome Med. 2021 Oct 14;13(1):164. doi: 10.1186/s13073-021-00985-w. Genome Med. 2021. PMID: 34649620 Free PMC article.
-
SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma.Proc Natl Acad Sci U S A. 2021 Sep 7;118(36):e2103154118. doi: 10.1073/pnas.2103154118. Proc Natl Acad Sci U S A. 2021. PMID: 34417349 Free PMC article.
-
Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2.mBio. 2021 Dec 21;12(6):e0231521. doi: 10.1128/mBio.02315-21. Epub 2021 Nov 16. mBio. 2021. PMID: 34781748 Free PMC article.
-
Characterization of SARS-CoV-2 Escape Mutants to a Pair of Neutralizing Antibodies Targeting the RBD and the NTD.Int J Mol Sci. 2022 Jul 25;23(15):8177. doi: 10.3390/ijms23158177. Int J Mol Sci. 2022. PMID: 35897753 Free PMC article.
Cited by
-
Omicron Sub-Lineage BA.5 and Recombinant XBB Evasion from Antibody Neutralisation in BNT162b2 Vaccine Recipients.Microorganisms. 2023 Jan 12;11(1):191. doi: 10.3390/microorganisms11010191. Microorganisms. 2023. PMID: 36677483 Free PMC article.
-
VIPERA: Viral Intra-Patient Evolution Reporting and Analysis.Virus Evol. 2024 Mar 6;10(1):veae018. doi: 10.1093/ve/veae018. eCollection 2024. Virus Evol. 2024. PMID: 38510921 Free PMC article.
-
Viral Population Heterogeneity and Fluctuating Mutational Pattern during a Persistent SARS-CoV-2 Infection in an Immunocompromised Patient.Viruses. 2023 Jan 19;15(2):291. doi: 10.3390/v15020291. Viruses. 2023. PMID: 36851504 Free PMC article.
-
Development and in vivo evaluation of a SARS-CoV-2 inactivated vaccine using high hydrostatic pressure.NPJ Vaccines. 2025 Apr 25;10(1):83. doi: 10.1038/s41541-025-01136-7. NPJ Vaccines. 2025. PMID: 40280930 Free PMC article.
References
-
- World Health Organization. Coronavirus disease (COVID-2019) dashboard [cited November, 27th 2021]. https://covid19.who.int.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous